Skip to main content
SpringerLink
Log in
Book cover

Multimodal Concepts for Integration of Cytotoxic Drugs pp 303–315Cite as

Applications to Gynecological Cancers

  • Chapter

  • 567 Accesses

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Airley RE et al (2003) GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer 104:85–91

    Article  PubMed  CAS  Google Scholar 

  • Bachtiary B et al (2005) Comparison of late toxicity between continuous low-dose-rate and pulsed-dose-rate brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys 63:1077–1082

    Article  PubMed  Google Scholar 

  • Baxter L, Jain R (1989) Transport of fluid and macromolecules in tumors I. Role of interstitial pressure and convection. Microvasc Res 37:77–104

    Article  PubMed  CAS  Google Scholar 

  • Bergers G et al (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111:1287–1295

    Article  PubMed  CAS  Google Scholar 

  • Bonner J et al (2004) Phase III evaluation of radiation with and without cetuximab for locoregionally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 60(Suppl): S147–S148

    Article  Google Scholar 

  • Brown JM (1979) Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism for reoxygenation. Br J Radiol 52:650–656

    PubMed  CAS  Google Scholar 

  • Brown JM (1993) SR 4233 (Tirapazamine): a new anti-cancer drug exploiting hypoxia in solid tumours. Br J Cancer 67:1163–1170

    PubMed  CAS  Google Scholar 

  • Burri P et al (2003) Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 56:494–501

    Article  PubMed  CAS  Google Scholar 

  • Bush RS et al (1978) Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 37(Suppl III):302–306

    CAS  Google Scholar 

  • Chan P et al (2004) A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer. Radiother Oncol 70:295–296

    Article  PubMed  CAS  Google Scholar 

  • Chen MD et al (1997) Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer. Gynecol Oncol 67:131–136

    Article  PubMed  CAS  Google Scholar 

  • Craighead PS, Pearcey R, Stuart G (2000) A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 48:791–795

    Article  PubMed  CAS  Google Scholar 

  • Dai Y et al (2005) The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma. Gynecol Oncol 97:96–103

    Article  PubMed  CAS  Google Scholar 

  • Dayes IS, Abuzallouf S (2005) Local tumour control in women with carcinoma of the cervix treated with the addition of nitroimidazole agents to radiotherapy: a meta-analysis. Br J Radiol 78:777–782

    Article  PubMed  CAS  Google Scholar 

  • De Vos FY et al (2004) Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer. Anticancer Res 24:345–348

    PubMed  Google Scholar 

  • Dische S et al (1984) The Medical Research Council trial of misonidazole in carcinoma of the uterine cervix. A report from the MRC Working Party on misonidazole for cancer of the cervix. Br J Radiol 57:491–499

    Article  Google Scholar 

  • Dische S et al (1993) A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: an interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix. Radiother Oncol 26:93–103

    Article  Google Scholar 

  • DiSilvestro P, Walker J, Morrsion A (2005) A phase I/II study of radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical cancer limited to the pelvis, a Gynecologic Oncology Group study. SGO Annual Meeting, 2005, Abstract 106

    Google Scholar 

  • Dong J et al (2004) VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J 23:2800–2810

    Article  PubMed  CAS  Google Scholar 

  • Duenas-Gonzalez A et al (2005) Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized phase II study. Int J Radiat Oncol Biol Phys 61:817–823

    Article  PubMed  CAS  Google Scholar 

  • Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(Suppl 16):15–18

    PubMed  CAS  Google Scholar 

  • Fyles A et al (2002) Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20:680–687

    Article  PubMed  CAS  Google Scholar 

  • Gaffney DK et al (2001) Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys 49:1213–1217

    Article  PubMed  CAS  Google Scholar 

  • Gaffney DK et al (2003) Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys 56:922–928

    Article  PubMed  CAS  Google Scholar 

  • Gaffney DK et al (2005) A phase I–II study of COX-2 inhibitor, Celebrex (Celecoxib) and chemoradiation in patients with kocally advanced cervical cancer: primary endpoint analysis of RTOG 0128. Int J Radiat Oncol Biol Phys 63(Suppl 1):S93–S94

    Article  Google Scholar 

  • Green J et al (2005) Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev CD002225

    Google Scholar 

  • Grigsby PW et al (1999) Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 44:513–517

    Article  PubMed  CAS  Google Scholar 

  • Harrison L, Blackwell K (2004) Hypoxia and anemia: Factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 9(Suppl 5):31–40

    Article  PubMed  Google Scholar 

  • Heldin CH et al (2004) High interstitial fluid pressure: an obstacle in cancer therapy. Nat Rev Cancer 4:806–813

    Article  PubMed  CAS  Google Scholar 

  • Henke M et al (2003) Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362:1255–1260

    Article  PubMed  CAS  Google Scholar 

  • Hernandez P, Olivera P, Duenas-Gonzales A, Perez-Pastenes MA, Zarate A, Maldonado V, Melendez-Zajgla J. (2001) Gemcitabine activity in cervical cancer cell lines. Cancer Chemother Pharmacol. 48(6):488–492

    Article  PubMed  CAS  Google Scholar 

  • Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011–1027

    Article  PubMed  CAS  Google Scholar 

  • Hockel M et al (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509–4515

    PubMed  CAS  Google Scholar 

  • Hockel M et al (1999) Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59:4525–4528

    PubMed  CAS  Google Scholar 

  • Hougardy BM et al (2005) Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance. Lancet Oncol 6:589–598

    Article  PubMed  CAS  Google Scholar 

  • Jain RK (1987) Transport of molecules in the tumor interstitium: a review. Cancer Res 47:3039–3051

    PubMed  CAS  Google Scholar 

  • Jain RK (1988) Determinants of tumor blood flow: a review. Cancer Res 48:2641–2658

    PubMed  CAS  Google Scholar 

  • Jain RK (2001) Normalizing tumor vasculature with antiangiogenic therapy: a new paradigm for combination therapy. Nat Med 7:987–989

    Article  PubMed  CAS  Google Scholar 

  • Jain RK (2005) Normalization of tumor vasculature: an emerging concept in a antiangiogenic therapy. Science 307:58–62

    Article  PubMed  CAS  Google Scholar 

  • Jasas KV et al (2004) Phase II study of erlotinib (OSA-774) in women with recurrent or metastatic endometrial cancer: NCIC CTG IND 148 (Abstract). J Clin Oncol 22(Suppl):453s

    Google Scholar 

  • Keys H et al (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154–1161

    Article  PubMed  CAS  Google Scholar 

  • Kim GE et al (2004) Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival. Clin Cancer Res 10:1366–1374

    Article  PubMed  CAS  Google Scholar 

  • Kim HJ et al (2003) High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 55:16–20

    Article  PubMed  CAS  Google Scholar 

  • Lanciano R et al (2005) A randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group Study. J Clin Oncol 23, epub

    Google Scholar 

  • Leborgne F, Leborgne JH, Doldan R, Zubizarreta E, Ortega B, Maisonneuve J, Museti E, Hekimian L, Mezzera J (1997) Induction chemotherapy and radiotherapy of advanced cancer of the cervic: a pilot study and phase III randomized trials. Int J Radiat Oncol Biol Phys. 37(2):343–350

    Article  PubMed  CAS  Google Scholar 

  • Lee C et al (2000) Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic and hypoxic conditions. Cancer Res 60:5565–5570

    PubMed  CAS  Google Scholar 

  • Leyland-Jones B (2003) Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 4:459–460

    Article  PubMed  Google Scholar 

  • Lorvidhaya V et al (2003) Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial. Int J Radiat Oncol Biol Phys 55:1226–1232

    Article  PubMed  CAS  Google Scholar 

  • Lukka H, Johnston M (2004) Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a metaanalysis. Clin Oncol (R Coll Radiol) 16:160–161

    CAS  Google Scholar 

  • Lyng H et al (2000) Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clin Cancer Res 6:1104–1112

    PubMed  CAS  Google Scholar 

  • Mackay H et al (2005) A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer. Clin Cancer Res 11:5526–5533

    Article  PubMed  CAS  Google Scholar 

  • Maduro JH et al (2003) Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev 29:471–488

    Article  PubMed  CAS  Google Scholar 

  • Mathur SP et al (2001) Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN). Am J Reprod Immunol 46:280–287

    Article  PubMed  CAS  Google Scholar 

  • Milosevic M et al (2001) Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res 61:6400–6405

    PubMed  CAS  Google Scholar 

  • Mollica FR, Jain RK, Netti PA (2003) A model for temporal heterogeneities of tumor blood flow. Microvasc Res 65:56–60

    Article  PubMed  Google Scholar 

  • Montana GS et al (2000) Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 48:1007–1013

    Article  PubMed  CAS  Google Scholar 

  • Moore DH et al (1998) Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 42:79–85

    Article  PubMed  CAS  Google Scholar 

  • Morgan B et al (2003) Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 21:3955–3964

    Article  PubMed  CAS  Google Scholar 

  • Morris M et al (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137–1143

    Article  PubMed  CAS  Google Scholar 

  • Mundt AJ et al (2001) Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies. Gynecol Oncol 82:333–337

    Article  PubMed  CAS  Google Scholar 

  • Mundt AJ et al (2004) Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies. Gynecol Oncol 92:801–805

    Article  PubMed  CAS  Google Scholar 

  • Nordsmark M et al (2003) Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother Oncol 67:35–44

    Article  PubMed  Google Scholar 

  • Okkan S et al (1996) A randomised study of ornidazole as a radiosensitiser in carcinoma of the cervix: long term results. Br J Cancer 74(Suppl 27):S282–S286

    CAS  Google Scholar 

  • Onishi T, Ohishi Y, Imagawa K, Ohmoto Y, Murata K (1999) An assessment of the immunological environment based on intratumoral cytokine production in renal carcinoma. BJU Int. 83(4):488–492

    Article  PubMed  CAS  Google Scholar 

  • Overgaard J (1994) Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. Oncol Res 6:509–510

    PubMed  CAS  Google Scholar 

  • Overgaard J et al (1989) Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 16:1069–1072

    PubMed  CAS  Google Scholar 

  • Padilla LA, Mitchell SK, Carson LF (2005) Phase I study of topotecan continuous infusion and weekly cisplatin with radiation therapy for locally advanced/recurrent cervical cancer. Proc Am Soc Clin Oncol, Abstract 5129

    Google Scholar 

  • Pearcey R, Brundage M. Drouin P, Jeffrey J, Johnston D, Lukka H. MacLean G, Souhami L, Stuart G, Tu D (2002) Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol. 20(4):891–893

    Article  Google Scholar 

  • Peters WA III et al (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606–1613

    PubMed  CAS  Google Scholar 

  • Pietras K et al (2001) Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 61:2929–2934

    PubMed  CAS  Google Scholar 

  • Pietras K et al (2002) Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res 62:5476–5484

    PubMed  CAS  Google Scholar 

  • Pignata S et al (2000) Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri. Ann Oncol 11:455–459

    Article  PubMed  CAS  Google Scholar 

  • Prise KM et al (2005) New insights on cell death from radiation exposure. Lancet Oncol 6:520–528

    Article  PubMed  CAS  Google Scholar 

  • Rakovitch E et al (1997) Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 38:979–987

    Article  PubMed  CAS  Google Scholar 

  • Randall ME et al (2006) Randomized phase III trial of wholeabdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24:36–44

    Article  PubMed  CAS  Google Scholar 

  • Rao GG et al (2005) Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Gynecol Oncol 96:168–172

    Article  PubMed  CAS  Google Scholar 

  • Roberts KB et al (2000) Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix. Int J Cancer 90:206–223

    Article  PubMed  CAS  Google Scholar 

  • Rose P et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144–1153

    Article  PubMed  CAS  Google Scholar 

  • Ryu HS et al (2000) High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion. Gynecol Oncol 76:320–325

    Article  PubMed  CAS  Google Scholar 

  • Stokes Z et al (2005) Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer. Gynecol Oncol 97:790–795

    Article  PubMed  CAS  Google Scholar 

  • Tannock IF et al (2005) The basic science of oncology, 4th edn. McGraw-Hill, Toronto, p 555

    Google Scholar 

  • Tseng CJ, Chang CT, Lai CH, Soong YK, Hong JH, Tang SG, Hsueh S. (1997) A randomized trial on concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol. 66(1):52–58

    Article  PubMed  CAS  Google Scholar 

  • Vaupel P (2004) Tumor microenvironmental physiology and its implication for radiation oncology. Semin Radiat Oncol 14:198–206

    Article  PubMed  Google Scholar 

  • Vrdoljak E et al (2005) Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study. Int J Radiat Oncol Biol Phys 61:824–829

    Article  PubMed  CAS  Google Scholar 

  • Whitney CW et al (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339–1348

    PubMed  CAS  Google Scholar 

  • Wiig H, Rubin K, Reed RK (2003) New and active role of the interstitium in control of interstitial fluid pressure: potential therapeutic consequences. Acta Anaesthesiol Scand 47:111–121

    Article  PubMed  CAS  Google Scholar 

  • Willett CG et al (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145–147

    Article  PubMed  CAS  Google Scholar 

  • Winter WE et al (2004) Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study. Gynecol Oncol 94:495–501

    Article  PubMed  CAS  Google Scholar 

  • Wong LC, Ngan HY, Cheung AN, Cheng DK, Ng TY, Choy DT. (1999) Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol. 17(7):2055–2060

    PubMed  CAS  Google Scholar 

  • Zarba JJ et al (2003) A phase I–II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma. Ann Oncol 14:1285–1290

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, ON, M5G 2M9, Canada

    Anthony W. Fyles MD & Michael Milosevic MD

  2. Department of Medical Oncology and Haematology, Princess Margaret Hospital, 610 University Avenue, Toronto, ON, M5G 2M9, Canada

    Amit Oza MD

Authors
  1. Anthony W. Fyles MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Milosevic MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amit Oza MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford School of Medicine, 269 Campus Drive Center for Clinical Science and Research, Rm 1255, Stanford, CA, 94305-5152, USA

    J. Martin Brown PhD

  2. Department of Human Oncology, University of Wisconsin Hospital Medical School, 600 Highland Ave., K4 312-3684, Madison, WI, 53792, USA

    Minesh P. Mehta MD

  3. Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Strasse 22, 81675, München, Germany

    Carsten Nieder MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fyles, A.W., Milosevic, M., Oza, A. (2006). Applications to Gynecological Cancers. In: Brown, J.M., Mehta, M.P., Nieder, C. (eds) Multimodal Concepts for Integration of Cytotoxic Drugs. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35662-2_20

Download citation

  • DOI: https://doi.org/10.1007/3-540-35662-2_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25655-7

  • Online ISBN: 978-3-540-35662-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation